ATE431426T1 - Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2 - Google Patents

Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2

Info

Publication number
ATE431426T1
ATE431426T1 AT07717962T AT07717962T ATE431426T1 AT E431426 T1 ATE431426 T1 AT E431426T1 AT 07717962 T AT07717962 T AT 07717962T AT 07717962 T AT07717962 T AT 07717962T AT E431426 T1 ATE431426 T1 AT E431426T1
Authority
AT
Austria
Prior art keywords
lrrk2
purifying
identifying
interacting molecules
indol ligand
Prior art date
Application number
AT07717962T
Other languages
English (en)
Inventor
Gerard Drewes
Carsten Hopf
Valerie Reader
Original Assignee
Cellzome Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ag filed Critical Cellzome Ag
Application granted granted Critical
Publication of ATE431426T1 publication Critical patent/ATE431426T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07717962T 2006-03-14 2007-03-13 Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2 ATE431426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78211906P 2006-03-14 2006-03-14
PCT/EP2007/052357 WO2007104763A1 (en) 2006-03-14 2007-03-13 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2

Publications (1)

Publication Number Publication Date
ATE431426T1 true ATE431426T1 (de) 2009-05-15

Family

ID=38093568

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07717962T ATE431426T1 (de) 2006-03-14 2007-03-13 Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2

Country Status (11)

Country Link
US (1) US8163511B2 (de)
EP (1) EP1866433B1 (de)
JP (1) JP2009529860A (de)
CN (1) CN101426927B (de)
AT (1) ATE431426T1 (de)
AU (1) AU2007224411B2 (de)
CA (1) CA2645214A1 (de)
DE (1) DE602007001103D1 (de)
DK (1) DK1866433T3 (de)
ES (1) ES2325797T3 (de)
WO (1) WO2007104763A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0706709D0 (en) 2007-04-05 2007-05-16 Medical Res Council Methods
US8206942B2 (en) 2007-04-05 2012-06-26 Medical Research Council Methods of identifying LRRK2 inhibitors
EP2045332B1 (de) 2007-10-05 2010-07-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Proteomweite Quantifizierung kleiner an zelluläre Zielproteine gebundener Moleküle
US20110111972A1 (en) * 2008-02-04 2011-05-12 Cellzome Ag Selectivity profiling of pi3k interacting molecules against multiple targets
GB2463656B (en) * 2008-09-18 2010-10-13 Medical Res Council Substrate of LRRK2 and methods of assessing LRRK2 activity
US8367349B2 (en) * 2010-04-19 2013-02-05 Medical Research Council Methods for identifying modulators of LRRK2
EP2710041A4 (de) * 2011-05-18 2014-11-05 Parkinson S Inst Assay zur bestimmung der lrrk2-aktivität bei morbus parkinson
CN105732639A (zh) 2012-06-29 2016-07-06 辉瑞大药厂 作为LRRK2抑制剂的4-(取代的氨基)-7H-吡咯并〔2,3-d〕嘧啶类
EP3083618B1 (de) 2013-12-17 2018-02-21 Pfizer Inc Neuartige 3,4-disubstituierte-1h-pyrrolo[2,3-b]pyridine und 4,5-disubstituierte 7h-pyrrolo[2,3-c]pyridazine als lrrk2-hemmer
CN108137586B (zh) 2015-09-14 2021-04-13 辉瑞大药厂 作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
CN111566081B (zh) * 2017-11-20 2021-04-06 天津安百胜医疗科技有限公司 一种双酰胺复合物及其制备方法和用途
CN112505328B (zh) * 2020-11-02 2024-02-13 武汉金开瑞生物工程有限公司 一种同位素标记试剂盒和标记方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081466A1 (en) * 2001-04-09 2002-10-17 Sugen, Inc. Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
AU2003253880A1 (en) 2002-07-15 2004-02-02 Sugen, Inc. Novel kinases
AU2006259153B2 (en) 2005-06-14 2012-04-12 Cellzome Gmbh Process for the identification of novel enzyme interacting compounds

Also Published As

Publication number Publication date
JP2009529860A (ja) 2009-08-27
DK1866433T3 (da) 2009-08-17
CA2645214A1 (en) 2007-09-20
WO2007104763A1 (en) 2007-09-20
US8163511B2 (en) 2012-04-24
ES2325797T3 (es) 2009-09-17
US20090220992A1 (en) 2009-09-03
EP1866433B1 (de) 2009-05-13
CN101426927B (zh) 2012-05-23
WO2007104763A9 (en) 2007-11-15
DE602007001103D1 (de) 2009-06-25
AU2007224411A1 (en) 2007-09-20
EP1866433A1 (de) 2007-12-19
CN101426927A (zh) 2009-05-06
AU2007224411B2 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
ATE431426T1 (de) Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
MX2007011859A (es) Compuestos mejorados farmacocineticamente.
ATE451363T1 (de) 3-(indazol-5-yl)-(1,2,4)triazinderivate und verwandte verbindungen als proteinkinaseinhibitoren zur behandlung von krebs
WO2008054599A3 (en) Rho kinase inhibitors
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
WO2010104598A3 (en) Kinase protein binding inhibitors
WO2005005462A3 (en) Blys antagonists and uses thereof
EP4091585C0 (de) Vorrichtung zur behandlung von refluxösophagitis
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
EP2014783A4 (de) Verfahren zur herstellung von feuerverzinktem stahlblech und feuerverzinktes stahlblech
DE602007005747D1 (de) System zur Entfernung von Kalkablagerungen
DE602006019022D1 (de) Vorrichtung zur Vereinzelung von Medien
DE602006015892D1 (de) Verfahren zur Beschichtung von metallen
WO2007048067A3 (en) C-kit oncogene mutations in melanoma
EP3734253C0 (de) Vorrichtung zur detektion der elution von proben
EP1848834A4 (de) Verfahren zur behandlung von kupferhaltigen materialien
EP1960416A4 (de) Verfahren zur aufreinigung von chenodesoxycholsäure
ATE551605T1 (de) Verfahren und vorrichtungen zur erkennung von biofilmen
TW200716132A (en) Novel chemical compounds
DE502005001884D1 (de) Verfahren zur Vergrößerung des Regelbereichs für die Gleichstellung von Einspritzmengenunterschieden
DE602006009901D1 (de) Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1866433

Country of ref document: EP